Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases

Details for Australian Patent Application No. 2004253478 (hide)

Owner Nereus Pharmaceuticals, Inc.

Inventors Macherla, Venkata Rami Reddy; Potts, Barbara Christine; Neuteboom, Saskia Theodora Cornelia; Palladino, Michael

Agent Fisher Adams Kelly

Pub. Number AU-A-2004253478

PCT Pub. Number WO2005/002572

Priority 60/566,952 30.04.04 US; 60/480,270 20.06.03 US

Filing date 18 June 2004

Wipo publication date 13 January 2005

International Classifications

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 33/00 (2006.01) Antiparasitic agents

A61P 33/02 (2006.01) Antiparasitic agents

A61P 33/06 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/002572 Priority application(s): WO2005/002572

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253479-Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes

2004253477-MPTENs as modifiers of the PTEN/IGF pathway and methods of use